About Brain Trust Bio
Brain Trust Bio is a company based in Brookhaven (United States) founded in 2019 by Chen Benkler and Nicholas M Boulis. Brain Trust Bio has raised $400 thousand across 1 funding round. Brain Trust Bio offers products and services including Continuous Intrathecal Drug Delivery Method. Brain Trust Bio operates in a competitive market with competitors including Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.
- Headquarter Brookhaven, United States
- Founders Chen Benkler, Nicholas M Boulis
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$400 K (USD)
in 1 rounds
-
Latest Funding Round
$400 K (USD), Seed
Mar 19, 2021
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brain Trust Bio
Brain Trust Bio offers a comprehensive portfolio of products and services, including Continuous Intrathecal Drug Delivery Method.
Administers drugs directly to CNS for enhanced efficacy and safety.
People of Brain Trust Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Brain Trust Bio
Brain Trust Bio has successfully raised a total of $400K through 1 strategic funding round. The most recent funding activity was a Seed round of $400 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Brain Trust Bio
Investment portfolio details for Brain Trust Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brain Trust Bio
Detailed financials for Brain Trust Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brain Trust Bio Comparisons
Peer comparison for Brain Trust Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brain Trust Bio
Brain Trust Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rhenovia Pharma, Afraxis, Wave Neuro, Neuro-Sys and Cerca Insights, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosimulation technology is provided for CNS drug discovery and development.
|
|
| Locked | Locked | Locked |
Provides comprehensive CNS pharmaceutical screening technologies for pre-clinical evaluations.
|
|
| Locked | Locked | Locked |
Preclinical services to neurological science are provided.
|
|
| Locked | Locked | Locked |
Preclinical CRO services for neurodegenerative diseases are offered by Neuro-Sys.
|
|
| Locked | Locked | Locked |
Provides preclinical services in behavioral pharmacology for research and development.
|
|
| Locked | Locked | Locked |
Provider of in vivo and ex vivo services to drug developers for neurological disorders
|
Detailed competitors of Brain Trust Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brain Trust Bio
Complete news archive for Brain Trust Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brain Trust Bio
Brain Trust Bio was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Brain Trust Bio is headquartered in Brookhaven, United States. It is registered at Brookhaven, Mississippi, United States.
Chen Benkler is the current CEO of Brain Trust Bio. They have also founded this company.
Brain Trust Bio is a funded company, having raised a total of $400K across 1 funding round to date.
Brain Trust Bio, based in Brookhaven, focuses on providing healthcare solutions, biopharma outsourcing, cro, preclinical studies, and neurology. Provider of contract based drugs delivery services for CNS disorders. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Brain Trust Bio's top competitors include Brains On-Line, Neuro-Sys and Rhenovia Pharma.
Brain Trust Bio offers Continuous Intrathecal Drug Delivery Method.